Table 1.
Summary of 35 included studies. Among them, 19 enrolled people with Alzheimer’s disease (AD) only, 12 studies involved people with mild cognitive impairment (MCI) only, and four studies included both AD and MCI.
| Study | Country | Study Design | Fall tracking tools | Sample size | Participant mean age (years) |
|---|---|---|---|---|---|
| Studies enrolling people with AD only | |||||
| Allan 2009 [31] | UK | OBS | Self-report (−) | 38 | 79 |
| Allan 2005 [29] | UK | OBS | Self-report (−) | 40 | 78.6 |
| Biju 2022 [32] | US | OBS | Self-report monthly calendars (+) | 48 | 74.9 |
| Camicioli 2004 [33] | Canada | OBS | Self-report verified by staff (+) | 42 | 82.6 |
| Cezar 2021 [47] | Brazil | RCT | Caregiver report (−) | 35 | 79.3 |
| Dev 2021 [34] | Pakistan | OBS | Self-report monthly phone calls (+) | 140 | 65 |
| Horikawa 2005 [30] | Japan | OBS | Caregiver report (+) | 104 | 74.1 |
| Kato-Narita 2009 [35] | Brazil | NRS | Self-report verified by caregiver (−) | 45 | 80 |
| Lorbach 2007 [36] | Australia | OBS | Self-report (−) | 21 | 79.3 |
| Oki 2021 [37] | Japan | OBS | Caregiver report (−) | 47 | 80.9 |
| Puente-Gonzalez 2021 [46] | Spain | RCT | Self-report verified by caregiver (−) | 72 | 76.7 |
| Roitto 2018 [38] | Finland | RCT | Caregiver report (−) | 179 | 77.6 |
| Soysal 2021 [39] | Turkey | OBS | Self-report (−) | 86 | 81 |
| Suttanon 2012 [42] | Australia | NRS | Self-report verified by caregiver (−) | 25 | 81 |
| Suttanon 2011 [40] | Australia | OBS | Self-report verified by caregiver (−) | 14 | 79.6 |
| Suttanon 2013 [65] | Australia | NRS | Self-report verified by caregiver (+) | 15 | 80.9 |
| Tchalla 2013 [43] | France | RCT | Caregiver and/or physician report (−) | 96 | 86.6 |
| Tsujimoto 2022 [44] | Japan | NRS | Self-report verified by caregiver (−) | 2,490 | 79 |
| Weller 2004 [45] | Canada | OBS | Self-report (−) | 528 | 83.2 |
| Studies enrolling people with MCI only | |||||
| Chantanachai 2022 [50] | Australia | OBS | Self-report monthly diaries (+) | 266 | 78.8 |
| Delbaere 2012 [12] * | Australia | NRS | Self-report monthly diaries with follow-up phone calls (+) | 77 | 77.5 |
| Le Floch 2021 [54] | France | OBS | Self-report interviews (−) | 86 | 70.9 |
| Lin 2022 [56] | Taiwan | NRS | Self-report (−) | 16 | NR |
| Liu-Ambrose 2018 [51] | Canada | NRS | Physician report (−) | 72 | 69.5 |
| Harper 2020 [55] | Australia | OBS | Self-report (−) | 61 | 81.1 |
| Makizako 2013 [48] | Japan | RCT | Self-report interviews (+) | 42 | 75.6 |
| Naharci 2021 [57] | Turkey | NRS | Self-report (−) | 152 | 80.1 |
| Pieruccini-Faria 2019 [53] | Canada | NRS | Self-report (−) | 52 | 72 |
| Pieruccini-Faria 2020 [52] | Canada | OBS | Self-report (−) | 110 | 74.3 |
| Snir 2019 [58] | Canada | OBS | Self-report interviews (−) | 43 | 74.5 |
| Uemura 2014 [49] | Japan | OBS | Self-report (−) | 938 | 71.9 |
| Studies enrolling people with AD and MCI | |||||
| Allali 2017 [60] | Australia, Belgium, France, India, Luxembourg, Switzerland, US | OBS | Self-report (−) | 806/529 $ | 76.5 |
| Ansai 2017 [59] | Brazil | OBS | Self-report verified by caregiver (−) | 38/40 $ | 76.7 |
| Borges 2015 [14] | Brazil | OBS | Self-report verified by caregiver (−) | 26/42 $ | 75 |
| Mignardot 2014 [61] | France | OBS | Self-report questionnaire (−) | 243/140 $ | 77.2 |
(−): Fall data were collected retrospectively. (+): Fall data were collected prospectively.
$:
Sample size for AD/sample size for MCI.
OBS = Observational Study. RCT = Randomized Control Trial. NRS = Non-randomized Controlled Study. UK = United Kingdom. US = United States. NR = Not reported.